Is CGP 41 251 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use CGP 41 251? Is CGP 41 251 safe for nursing mother and child? Does CGP 41 251 extracts into breast milk? Does CGP 41 251 has any long term or short term side effects on infants? Can CGP 41 251 influence milk supply or can CGP 41 251 decrease milk supply in lactating mothers?
Answer by DrLact: About CGP 41 251 usage in lactation
No information is available on the clinical use of CGP 41 251 during breastfeeding. Because CGP 41 251 and its active metabolites are 99.8% bound to plasma proteins, the amount in milk is likely to be low. The manufacturer recommends that breastfeeding be discontinued during CGP 41 251 therapy and for at least 4 months after the last dose. Avoiding breastfeeding is particularly important when CGP 41 251 is given with other cancer chemotherapy agents.
Alternate Drugs
Mercaptopurine(Safe)
Erlotinib(Unsafe)
Thioguanine(Dangerous)
Hydroxyurea(Low Risk)
Nilotinib(Unsafe)
Etoposide(Dangerous)
Letrozole(Dangerous)
Trastuzumab(Unsafe)
Gemcitabine(Dangerous)
Doxorubicin(Dangerous)
Exemestane(Dangerous)
Pazopanib(Unsafe)
Dactinomycin(Dangerous)
Cyclophosphamide(Dangerous)
Cisplatin(Unsafe)
Imatinib(Unsafe)
Docetaxel(Dangerous)
Busulfan(Dangerous)
Ipilimumab(Unsafe)
Nivolumab(Unsafe)
Azelaic Acid(Safe)
Cetuximab(Unsafe)
Vinblastine(Dangerous)
Carboplatin(Dangerous)
Bleomycin(Dangerous)
Paclitaxel(Dangerous)
Vinorelbine(Dangerous)
Cladribine(Dangerous)
Fluorouracil(Dangerous)
Alemtuzumab(Low Risk)
Dacarbazine(Dangerous)
Vincristine(Dangerous)
Rituximab(Low Risk)
Tamoxifen(Dangerous)
Mitoxantrone(Dangerous)
Dasatinib(Unsafe)
Bevacizumab(Low Risk)
Nilotinib(Unsafe)
Gemcitabine(Dangerous)
Pazopanib(Unsafe)
Imatinib(Unsafe)
Allopurinol(Safe)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Erlotinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Erlotinib(Unsafe)